29 Oct, 2009 in
News & Articles by
admin
Mesothelioma and Asbestos
Articles, News, and Information – newbFAQFeatured
Does anyone know if Peritoneal Mesothelioma has the same awareness color for just Mesothelioma which is Pearl? What is an adenocarcinoma? With the cancer mesothelioma, what effect does metastasis to the lymph nodes have on the patient? Why are Families that Lives have been affected by MESOTHELIOMA able to be compensated but Families of Agent Or? Is there a cure for mesothelioma?
|
Meda Pharmaceuticals is launching BioDelivery Sciences International’s (BDSI) drug Onsolis in mid-October for take by patients in the United States who suffer from mesothelioma or other painful cancers. Onsolis (fentanyl buccal soluble film) has been approved by the Food as well as Drug Administration (FDA) for the treatment of breakthrough cancer pain in mesothelioma patients as well as other cancer patients age 18 as well as older who are already utilizing opioid drug therapy to treat their persistent cancer pain. The drug will be marketed specifically to oncologists, pain management physicians as well as other health care professionals who treat patients with breakthrough cancer pain. For the filled story, go to Business Wire. |
Related Posts
- BDSI receives US patent for Onsolis as well as BEMA drug delivery platform
- Cancer pain drug Abstral filing accepted for review by FDA
- Cancer pain drug Onsolis approved for take in Canada
- 75% of adult cancer patients struggle with breakthrough cancer pain
- University of Miami will treat patients with pain therapy health examination device
